Telomere and Telomerase as Targets for Cancer Therapy

被引：44

作者：

Tian, Xiaoping ^{[1
]}

Chen, Bo ^{[1
]}

Liu, Xiaochuan ^{[1
]}

机构：

[1] Zhejiang Sci Tech Univ, Bioengn Inst, Life Sci Coll, Hangzhou 310018, Peoples R China

来源：

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY | 2010年 / 160卷 / 05期

关键词：

Telomere; Telomerase; Telomere dysfunction; Telomerase RNA; Cancer therapy; HTERT MESSENGER-RNA; REVERSE-TRANSCRIPTASE EXPRESSION; TUMOR-ASSOCIATED ANTIGEN; CYTOTOXIC T-LYMPHOCYTES; SINGLE-STRAND OVERHANG; GROWTH IN-VITRO; SUICIDE GENE; STEM-CELLS; CELLULAR SENESCENCE; INHIBITION;

D O I：

10.1007/s12010-009-8633-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Telomere maintenance and telomerase reactivation is essential for the transformation of most human cancer cells. Telomere shortening to the threshold length, mutations of the telomere-associated proteins, and/or telomerase RNA lead to telomeric dysfunction and therefore genomic instability. Telomerase up-regulation in 85% of human cancer cells has become a hallmark of cancers, hence a promising target for anticancer therapy. In this review, we discuss the mechanism of cancer due to telomere dysfunction and the resulting biological effects, the control of telomerase activity, and the new developments in cancer therapies targeting telomere and telomerase.

引用

页码：1460 / 1472

页数：13

共 50 条

[41] Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer
Heeg, Steffen
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2015, 8 : 171 - 180
[42] Telomerase is not a major determinant of telomere length in colorectal cancer.
Chida, M
Kinouchi, Y
Takagi, S
Hiwatashi, N
Nagashima, F
Toyota, T
GASTROENTEROLOGY, 1998, 114 (04) : A578 - A578
[43] Targeting telomerase for cancer therapy
Guterres, Adam N.
Villanueva, Jessie
ONCOGENE, 2020, 39 (36) : 5811 - 5824
[44] TELOMERE DYNAMICS AND TELOMERASE ACTIVATION IN TUMOR PROGRESSION - PROSPECTS FOR PROGNOSIS AND THERAPY
HEALY, KC
ONCOLOGY RESEARCH, 1995, 7 (3-4) : 121 - 130
[45] Telomerase inhibition as cancer therapy
Saretzki, G
CANCER LETTERS, 2003, 194 (02) : 209 - 219
[46] Targeting telomerase for cancer therapy
Adam N. Guterres
Jessie Villanueva
Oncogene, 2020, 39 : 5811 - 5824
[47] Targeting Telomerase for Cancer Therapy
Ruparel, Shivani
Siddiqa, Aisha
Marciniak, Robert A.
CURRENT CANCER THERAPY REVIEWS, 2011, 7 (03) : 215 - 226
[48] Telomere maintenance without telomerase
Biessmann, H
Mason, JM
CHROMOSOMA, 1997, 106 (02) : 63 - 69
[49] Telomerase Mechanism of Telomere Synthesis
Wu, R. Alex
Upton, Heather E.
Vogan, Jacob M.
Collins, Kathleen
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 86, 2017, 86 : 439 - 460
[50] Telomere protein complexes and interactions with telomerase in telomere maintenance
Pinto, Alexander Ruvantha
Li, He
Nicholls, Craig
Liu, Jun-Ping
FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 187 - 207

← 1 2 3 4 5 →